Martingale Asset Management L P Surmodics Inc Transaction History

Martingale Asset Management L P

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$29.44 - $37.31 $22,080 - $27,982	-750 Reduced 10.2%	6,603 $225,000
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $239,458 - $323,152	-8,303 Reduced 53.03%	7,353 $224,000
Q1 2022 May 12, 2022	BUY	$40.68 - $49.72 $4,068 - $4,972	100 Added 0.64%	15,656 $709,000
Q4 2021 Feb 11, 2022	SELL	$43.21 - $57.6 $8,685 - $11,577	-201 Reduced 1.28%	15,556 $749,000
Q3 2021 Nov 12, 2021	BUY	$52.8 - $60.32 $483,120 - $551,928	9,150 Added 138.49%	15,757 $876,000
Q2 2021 Aug 13, 2021	SELL	$51.29 - $59.15 $5,129 - $5,915	-100 Reduced 1.49%	6,607 $358,000
Q1 2021 May 13, 2021	BUY	$42.18 - $56.07 $29,399 - $39,080	697 Added 11.6%	6,707 $376,000
Q4 2020 Feb 10, 2021	SELL	$35.18 - $43.52 $1.02 Million - $1.26 Million	-28,900 Reduced 82.78%	6,010 $261,000
Q3 2020 Nov 12, 2020	BUY	$37.98 - $48.72 $744,673 - $955,253	19,607 Added 128.13%	34,910 $1.36 Million
Q2 2020 Aug 10, 2020	BUY	$31.07 - $44.74 $475,464 - $684,656	15,303 New	15,303 $661,000

124

13.2M

25.5K

3.4K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $539M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.